Aclaris Therapeutics ACRS
NASDAQ ACRS
$5.34 +0.06 (+1.23%)
As of: Sep 30, 2026 · 1:51 PM EDT

Aclaris Therapeutics, Inc. (ACRS) Receivables - Other (2019 - 2021)

Updated

Aclaris Therapeutics' Receivables - Other was $24,000 in Q4 2021, down 92.0% from $300,000 a year earlier and unchanged from the prior quarter.

Analysis

Aclaris Therapeutics, Inc. (ACRS) Receivables - Other (2019 - 2021) Analysis & Trends

From Q3 2019 onward, Aclaris Therapeutics has reported Receivables - Other for 10 quarters.

  • In earlier years, Receivables - Other was $300,000 in FY2020 (+200.0%) and $100,000 in FY2019.
  • Quarterly Receivables - Other has moved between $20,000 (Q1 2021) and $300,000 (Q4 2020) over five years.
  • Compared with a year earlier, Receivables - Other has declined for four straight quarters, with growth averaging 5.7% over the last six quarters.
  • Per Business Quant data, ACRS's Receivables - Other in the three quarters before Q4 2021 was $24,000 (Q3 2021), $24,000 (Q2 2021) and $20,000 (Q1 2021).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 24,000.00
Sep 30, 2021 24,000.00
Jun 30, 2021 24,000.00
Mar 31, 2021 20,000.00
Dec 31, 2020 300,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 300,000.00
Mar 31, 2020 200,000.00
Dec 31, 2019 100,000.00
Sep 30, 2019 100,000.00
API Access

Aclaris Therapeutics, Inc. Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ACRS&period=max&api_key=YOUR_API_KEY